INTRODUCTION
Since the 1930's, there has been a clear desire to eliminate, through endoscopic methods, large tumoral or iatrogenic obstructions of the airways. In 1935, Kramer and Som (1) published the first results of endoscopic resection in 20 patients with bronchial adenoma, observing years later that of the 14 patients that they had considered adequately treated, 50% were cured or free of symptoms (2) . Further attempts to endoscopically resect malignant lesions were soon abandoned because postulated improvements in ventilation were offset by the significant risk of hemorrhagic complications (3) . More recently, transbronchoscopic cryosurgery (4) and intraluminal radiotherapy (5) have been tried with limited benefits in the removal of the bronchial obstruction.
Endobronchial laser treatment has shown promise since the first report of Strong and colleagues in 1974 (6) . Since tinued to advance. Since the 1980's, laser bronchoscopy has reached its apogee, as demonstrated in the extensive published series (7) (8) (9) (10) . This report presents some considerations after 9 years experience with 2015 procedures.
MATERIALS AND METHODS
Between 1984 and 1993 we performed a total of 2105 treatments in 1210 patients (Fig. 1 ). In our system, the laser is transmitted from the generator to the tissues through a fiber 0.6 mm in diameter, surrounded by a Teflon sleeve through which gas (nitrogen) is passed to obtain cooling and to prevent combustion. Since the light of the Nd-YAG laser is invisible to the human eye, a coaxial red helium-neon laser is used for targeting. The distal end is protected by a metallic tube of stainless steel to avoid ignition by overheating during treatment. Recently, disposable fibers have been developed which allow either contact or non-contact applications. These fibers are able to cut (approximating the CO2 effect in the tissue) and to coagulate.
Endoscopes
The rigid bronchoscope (Fig. 2) Once the patient is anesthetized and appropriate monitoring is established, we proceed to intubation and ventilation through the rigid bronchoscope. We then inspect the airway. Care is taken to avoid contact with the lesion at this point so we can best define the limits of the lesion and avoid hemorrhage, which would obscure the field. A thorough understanding of thoracic anatomy is necessary to prevent iatrogenic damage to important surrounding structures. The limits of the lesion are defined by imaging studies (i.e., X-rays, tomograms, computed tomogra- phy scans, esophograms, etc.) performed in addition to routine preoperative studies.
The first few bursts of laser photoradiation are used to estimate the tissue energy absorption characteristics and the depth of the laser penetration. We vary the power and the duration of the laser shots as the treatment progresses. We use short bursts at high energy to resect tumor and longer bursts at low energy to coagulate. We never use a continuous pattern of firing as we consider this to be unsafe. The beam of the Nd-YAG laser, which is always coaxial with the fiber could damage surrounding structures. The tip of the bronchoscope can be used as an additional aid to ablate and remove tissue incised by the laser beam.
RESULTS
Our total experience include 2105 resections in 1210 patients. As laser photoresection is almost always a palliative rather than a curative procedure, immediate results were classified as excellent, good or poor according to initial improvement of symptoms and airway diameter.
Excellent results were achieved in 71.6% of tracheal tumors. Of the patients with tracheal stenosis, 35% had recurrences and underwent a repeat laser photoresection, surgery or prosthesis placement (Fig. 3 ). In the past 2 years, we placed a total of 125 stents for both malignant tumors (84/68%) and benign tracheal stenosis (41/32%) (Fig. 4) . The most significant complication of stenting was migration which was greater with underlying benign pathology than with underlying malignant pathology.
DISCUSSION
Malignant Tumor Pathology Laser photoresection of tumors is limited to inoperable cases. These include cases of tumor that has gone beyond the limits of resection or in which the condition of the patient precludes surgery. The objective always has to be relief of obstruction (Fig. 5) Treatment aims to reestablish the airway by endoscopic procedures or by an external surgical approach. Surgical procedures such as resection of the affected rings and endto-end anastomosis, tracheoplasty, etc., carry certain potential risks not usually associated with endoscopic resection. These include an increased anesthesia time, prolonged hospitalization, loss of blood and problems related to the transfusion, and postoperative discomfort of the patient. Repeated procedures, if needed, are difficult.
Endoscopic methods include traditional dilatation, which in itself is not free of risk, prolonged placement of a fixed dilating prothesis, the use of lasers, or combined laser and stenting (Fig. 6) The treatment of tracheal stenosis with a laser treatment is simple and results can be spectacular. The airway is reestablished in a few minutes, independent of the grade of obstruction or of location.
This makes laser treatment the fastest and safest method for tracheal stenosis. Unfortunatelly, many of these reopened stenoses will not remain open for more than 2 months because the mechanism for formation of tracheal stenosis involves not only the growth of granulation or fibrotic tissue into the tracheal lumen, but also a failure of the supporting structures. The conclusion of many authors (7) (8) (9) (23) (24) (25) is that the best results are obtained in patients with diaphragmatic stenosis extending less than 1 cm along the longitudinal axis of the trachea and with no destruction of the wall structures. In these patients, the effects of treatment ofthe stenosis are usually permanent. In patients with more complex stenosis, the recurrence rate varies between 50 and 75% (23) (24) (25) (26) . The recommendation is to always try laser treatment first and, if there is recurrence, proceed to surgical correction or stent placement (27) (28) (29) (30) (31) (32) (8) .
When significant hemorrhage is produced during treatment, steps are taken to contain the hemorrhage and to keep the airways well ventilated. If bleeding is produced by a lesion situated in the trachea, we pass the lesion with the rigid bronchoscope. Our goal is to initially compress the point of hemorrhage and ventilate the bronchial tree. We later coagulate with the laser. With bronchial lesions, we withdraw the bronchoscope to the trachea to ventilate the contralateral side while we aspirate the blood out to the airway and try to stop the hemorrhage with local intervention such as using the laser for coagulation.
Perforation of surrounding structures is very rare, but when it does occur, it is usually catastrophic. It is best to avoid this by using good technique, avoiding direct laser shots to the tracheal or bronchial walls and not stubbornly continuing the resection when the involved tissue does not absorb the laser beam well since this can be deeply damaging the surrounding structures (7, 33, 34) .
The mortality rate during treatment varies according to the reported series. It is lower among those using a rigid bronchoscope (7-9) than in those using a fiberoptic bronchoscope (35, 36) . Despite the fact that some authors (15, (37) (38) (39) find no difference in the results with both methods, we believe the margin of safety with the rigid bronchoscope is superior to the flexible bronchoscope. This is because of better visibility and the ability to introduce aspiration tubes and forceps, effect compression, and incise tissues with the laser. Also, the time needed for the intervention is less. The flexible bronchoscope can be introduced through the rigid bronchoscope to treat more distal areas. All these make treatment with a rigid bronchoscope superior to using a flexible bronchoscope alone. Risks are further minimized using laser energies of no greater than 45 watts and by maintaining oxygen levels of less than 50% during laser emission. There are several reports like that of Casey and colleagues (41) , of an endotracheal ignition of the fiberbronchoscope when using high energy laser bursts in the presence of high concentrations of oxygen. Finally, other infrequent complications have been reported. These include pneumothorax or pneumomediastinum which usually occur in relation to mechanical ventilation during anesthesia, especially when jet ventilation is used (42, 43) . There has even been a case reported of the loss of the metallic protector of the distal end of the laser fiber because of excessive heating (44) .
CONCLUSION
Overall, laser bronchoscopy has made a significant contribution to the treatment of intraluminal airway disease.
It can be used in conjunction with other forms of therapy. 
